Deploys growth and crossover capital into software and healthcare services across North America, emphasizing revenue-driven scale-ups and board-level governance. Steve Solano combines prior operating roles and buy-side experience to source deals, structure minority and majority investments, and guide exits via strategic sales or IPOs. Holds an MBA and has worked with corporate development teams and private capital sponsors, providing operational playbooks and investor reporting frameworks that appeal to institutional LPs.
Deploys growth and crossover capital into software and healthcare services across North America, emphasizing revenue-driven scale-ups and board-level governance. Steve Solano combines prior operating roles and buy-side experience to source deals, structure minority and majority investments, and guide exits via strategic sales or IPOs. Holds an MBA and has worked with corporate development teams and private capital sponsors, providing operational playbooks and investor reporting frameworks that appeal to institutional LPs.
Focuses on growth and crossover capital for software and healthcare services, prioritizing revenue-driven scale-ups in North America. Investment decisions emphasize strong commercial traction, unit-economics discipline, and governance readiness for board-level oversight. Capital is allocated across minority and control structures to balance upside capture with operational influence; time horizon is typically medium-to-long, targeting strategic sales or IPO exits. Due diligence centers on go-to-market metrics, recurring revenue durability, and regulatory resilience. Offers an operator-investor approach—deploying playbooks for commercial scaling, KPI-driven reporting, and active portfolio governance to de-risk expansion and align with institutional LP return expectations.
Focuses on growth and crossover capital for software and healthcare services, prioritizing revenue-driven scale-ups in North America. Investment decisions emphasize strong commercial traction, unit-economics discipline, and governance readiness for board-level oversight. Capital is allocated across minority and control structures to balance upside capture with operational influence; time horizon is typically medium-to-long, targeting strategic sales or IPO exits. Due diligence centers on go-to-market metrics, recurring revenue durability, and regulatory resilience. Offers an operator-investor approach—deploying playbooks for commercial scaling, KPI-driven reporting, and active portfolio governance to de-risk expansion and align with institutional LP return expectations.
| Trades 206 | Longs Won 149/206 72% | Profit Factor 16.93 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $581,190.72 |
| Average Win $210,056.93 | Best Trade (Jul 10) $5.65M | Sharpe Ratio -192.9 |
| Average Loss -$32,438.62 | Worst Trade (Jul 16) -$722,432.69 | Z-Score 7.69 (100%) |
| Commissions $0 | Avg. Trade Length 1y 1d | Expectancy $142,958.65 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 6,061 | 5,455 | 4,848 | 4,242 | 3,636 | 3,030 | 2,424 | 1,818 | 1,212 | 606 |